BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2949771)

  • 1. The effect of tetracycline and erythromycin in a model of acne-type inflammation.
    Dalziel K; Dykes PJ; Marks R
    Br J Exp Pathol; 1987 Feb; 68(1):67-70. PubMed ID: 2949771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and bacteriological evaluation of tetracycline and erythromycin in acne vulgaris.
    Al-Mishari MA
    Clin Ther; 1987; 9(3):273-80. PubMed ID: 2955899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Double-blind group comparison of topical meclocycline, erythromycin and placebo in the treatment of papulo-pustulosa acne].
    Rozman TA; Klövekorn G; Kompa H
    Z Hautkr; 1984 Dec; 59(23):1623-34. PubMed ID: 6240840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils.
    Jain A; Sangal L; Basal E; Kaushal GP; Agarwal SK
    Dermatol Online J; 2002 Oct; 8(2):2. PubMed ID: 12546757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of systemic erythromycin stearate on the inflammatory lesions and skin surface fatty acids in acne vulgaris.
    Bleeker J; Hellgren L; Vincent J
    Dermatologica; 1981; 162(5):342-9. PubMed ID: 6454598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation due to intra-cutaneous implantation of stratum corneum.
    Dalziel K; Dykes PJ; Marks R
    Br J Exp Pathol; 1984 Feb; 65(1):107-15. PubMed ID: 6230095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria.
    Eady EA; Bojar RA; Jones CE; Cove JH; Holland KT; Cunliffe WJ
    Br J Dermatol; 1996 Jan; 134(1):107-13. PubMed ID: 8745894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meclosorb, a new topical antibiotic agent in the treatment of acne vulgaris: a double-blind clinical study.
    Hjorth N; Schmidt H; Thomsen K; Dela K
    Acta Derm Venereol; 1984; 64(4):354-7. PubMed ID: 6209900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
    McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral trimethoprim versus oxytetracycline in the treatment of inflammatory acne vulgaris.
    Gibson JR; Darley CR; Harvey SG; Barth J
    Br J Dermatol; 1982 Aug; 107(2):221-4. PubMed ID: 6213255
    [No Abstract]   [Full Text] [Related]  

  • 13. The comparative efficacy of benzoyl peroxide 5%/erythromycin 3% gel and erythromycin 4%/zinc 1.2% solution in the treatment of acne vulgaris.
    Chu A; Huber FJ; Plott RT
    Br J Dermatol; 1997 Feb; 136(2):235-8. PubMed ID: 9068739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriological examination of rectal specimen during long-term oxytetracycline treatment for acne vulgaris.
    Schmidt H; From E; Heydenreich G
    Acta Derm Venereol; 1973; 53(2):153-6. PubMed ID: 4120960
    [No Abstract]   [Full Text] [Related]  

  • 15. Dietary effect of lactoferrin-enriched fermented milk on skin surface lipid and clinical improvement of acne vulgaris.
    Kim J; Ko Y; Park YK; Kim NI; Ha WK; Cho Y
    Nutrition; 2010 Sep; 26(9):902-9. PubMed ID: 20692602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [External erythromycin therapy of acne].
    Schmidt JB; Knobler R; Neumann R; Poitschek C
    Z Hautkr; 1983 Dec; 58(24):1754-60. PubMed ID: 6229931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythromycin inhibits wear debris-induced inflammatory osteolysis in a murine model.
    Ren W; Wu B; Peng X; Mayton L; Yu D; Ren J; Chen BD; Wooley PH
    J Orthop Res; 2006 Feb; 24(2):280-90. PubMed ID: 16435361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oxytetracycline--mechanism of action and application in skin diseases].
    Olszewska M
    Wiad Lek; 2006; 59(11-12):829-33. PubMed ID: 17427500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythromycin and penetrating agents containing ointment in acne vulgaris therapy.
    Kasprowicz A; Krówczyński L; Jachowicz R; Białecka A
    Pol J Pharmacol Pharm; 1988; 40(5):465-9. PubMed ID: 2978177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of tetracycline therapy in acne vulgaris on amount and composition of skin surface lipids in various dosages. Gas chromatographic studies of its action mechanism].
    Gloor M; Kionke M; Friederich HC
    Arch Dermatol Forsch; 1972; 243(4):335-40. PubMed ID: 4263449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.